Efficacy of treatment for patients with achalasia depends on the distensibility of the esophagogastric junction

WO Rohof, DP Hirsch, BF Kessing, GE Boeckxstaens - Gastroenterology, 2012 - Elsevier
… , 4 Because the neuronal loss is irreversible, treatment of achalasia is limited to disruption of
… to reduce LES tone and improve bolus transport across the esophagogastric junction (EGJ). …

Treatment in esophagogastric junction cancer: Past, present and future

C Pericay, I Macías-Declara, V Arrazubi, L Vilà… - Cirugía Española …, 2019 - Elsevier
… in survival when we administer preoperative treatment, with evidence in favor of CRTx and
CTx. Studies are already underway with targeted treatment that aim to increase the activity of …

Efficacy and safety of endoscopic submucosal dissection for tumors of the esophagogastric junction

N Kakushima, N Yahagi, M Fujishiro, S Kodashima… - …, 2006 - thieme-connect.com
esophagogastric junction (EGJ) has been considered a difficult location for endoscopic
treatment of … The aim of this study was to evaluate the efficacy and safety of ESD for EGJ tumors. …

Safety, efficacy, and long-term outcomes for endoscopic submucosal dissection of early esophagogastric junction cancer

M Omae, J Fujisaki, Y Horiuchi, N Yoshizawa… - Gastric Cancer, 2013 - Springer
… Early esophagogastric junction (EGJ) cancer is currently being treated in the same way as
… Our aim was to retrospectively evaluate the safety and efficacy of ESD in treating early EGJ …

Comparative efficacy of treatments for previously treated patients with advanced esophageal and esophagogastric junction cancer: A network meta-analysis

S Lin, T Liu, J Chen, G Li, J Dang - Plos one, 2021 - journals.plos.org
… the esophagogastric junction (EGJ). Systemic chemotherapy (CT) plays an essential role in
the treatment … , researchers have been investigating the efficacy of various target agents for a …

[HTML][HTML] Multimodal treatment strategies in esophagogastric junction cancer: a Western perspective

TO Goetze, SE Al-Batran, F Berlth… - Journal of Gastric …, 2019 - ncbi.nlm.nih.gov
treatment principle in Japan and Korea, and thereafter, subsequent studies demonstrated
strong evidence in favor of the efficacy … of the “esophagogastric junction,” and more than 14% …

Clinical efficacy of endoscopic submucosal dissection for adenocarcinomas of the esophagogastric junction

Y Nagami, H Machida, M Shiba… - Endoscopy …, 2014 - thieme-connect.com
… Although the incidence of adenocarcinoma of the esophagus and esophagogastric junction
(EGJ) is dramatically increasing in Western countries, [1] [2] esophageal adenocarcinoma (…

Esophageal and esophagogastric junction cancers, version 1.2015

JA Ajani, TA D'Amico, K Almhanna, DJ Bentrem… - Journal of the National …, 2015 - jnccn.org
… Postoperative Treatment: Postoperative treatment is based on the surgical margins, nodal
status, and histology. The efficacy of postoperative treatment has not been established in …

Esophagogastric junction outflow obstruction: current approach to diagnosis and management

TA Zikos, G Triadafilopoulos, JO Clarke - Current gastroenterology reports, 2020 - Springer
… We summarize the current epidemiology, presentation, diagnostic workup, and treatment
of esophagogastric junction outflow obstruction (EGJOO). We also propose a treatment

[HTML][HTML] Treatment of esophagogastric junction carcinoma: an unsolved debate

M Orditura, G Galizia, E Lieto, F De Vita… - World journal of …, 2015 - ncbi.nlm.nih.gov
… to the esophagogastric junction. Finally, AEG type III is a subcardial gastric carcinoma
infiltrating the EGJ or the distal esophagus from below, and lies 2-5 cm distal to the EGJ. Overall, …